Hyperlipidemia
403
21
23
295
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Published Results
72 trials with published results (18%)
Research Maturity
295 completed trials (73% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
3.7%
15 terminated out of 403 trials
95.2%
+8.7% vs benchmark
28%
112 trials in Phase 3/4
24%
72 of 295 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 295 completed trials
Clinical Trials (403)
Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy
A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)
Chronic Kidney Disease and Metabolic Disorders in the Elderly
Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy
Evaluating the Effectiveness of a Multi-level Health-Related Social Needs Initiative
Lipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins
Duke Cardiometabolic Prevention Clinic's Impact on High-risk Cardiovascular Patients With Uncontrolled Risk Factors
Prospective Exploratory Study on the Comprehensive Application Effectiveness of Exercise Prescription Decision Support Tools in the Management of Patients With "Four Highs" (Hypertension, Hyperglycemia, Hyperlipidemia, Hyperuricemia)
Biosynthesis of PGD2 in Vivo
Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia
A Trial to Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia
A Study to Evaluate COR-1004 in Adult Volunteers.
Implementation of an Algorithm- and Multi-professional Team-supported Strategy to Improve Lipid Management of Patients With Atherosclerotic Cardiovascular Disease
A Clinical Trial of HRS-1301 on the Pharmacokinetics of Rosuvastatin Calcium Tablets in Healthy Subjects
A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-231A and AD-231B and AD-231C
Rapid Escalation of LipiD Lowering Therapy to Reduce RecUrrent Cardiovascular Event
Inspire HER: Inspiring the Heart and Emotions for Radical Health
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-1301 in Healthy Subjects
"Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Revascularization Patients
A Phase II Study To Evaluate the Efficacy And Safety Of HRS-1301 In Participants With Dyslipidemia